SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-010632
Filing Date
2020-04-30
Accepted
2020-04-30 16:17:29
Documents
114
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2019_enlivextherap.htm 20-F 1475805
2 DESCRIPTION OF ORDINARY SHARES f20f2019ex2-1_enlivex.htm EX-2.1 23187
3 ENLIVEX THERAPEUTICS LTD. 2019 GLOBAL SHARE INCENTIVE PLAN f20f2019ex4-3_enlivex.htm EX-4.3 92748
4 EMPLOYMENT AGREEMENT BETWEEN THE COMPANY AND OREN HERSHKOVITZ, DATED AS OF NOVEM f20f2019ex4-8_enlivex.htm EX-4.8 13210
5 RESEARCH AGREEMENT, BETWEEN THE COMPANY AND CELL GENERATION (C-G) LTD., DATED MA f20f2019ex4-15_enlivex.htm EX-4.15 168270
6 LIST OF SUBSIDIARIES OF ENLIVEX THERAPEUTICS LTD f20f2019ex8-1_enlivex.htm EX-8.1 3383
7 CERTIFICATION f20f2019ex12-1_enlivex.htm EX-12.1 7099
8 CERTIFICATION f20f2019ex12-2_enlivex.htm EX-12.1 7014
9 CERTIFICATION f20f2019ex13-1_enlivex.htm EX-13.1 3343
10 CERTIFICATION f20f2019ex13-2_enlivex.htm EX-13.2 3292
11 CONSENT OF CONSENT OF YAREL + PARTNERS f20f2019ex15-1_enlivex.htm EX-15.1 2408
18 GRAPHIC image_001.jpg GRAPHIC 29042
19 GRAPHIC image_002.jpg GRAPHIC 29402
20 GRAPHIC image_003.jpg GRAPHIC 21164
21 GRAPHIC image_004.jpg GRAPHIC 26566
22 GRAPHIC image_005.jpg GRAPHIC 29119
23 GRAPHIC fin_001.jpg GRAPHIC 32112
24 GRAPHIC ex15-1_001.jpg GRAPHIC 8233
25 GRAPHIC ex4-8_001.jpg GRAPHIC 362027
26 GRAPHIC ex4-8_002.jpg GRAPHIC 434100
27 GRAPHIC ex4-8_003.jpg GRAPHIC 435240
28 GRAPHIC ex4-8_004.jpg GRAPHIC 455505
29 GRAPHIC ex4-8_005.jpg GRAPHIC 434279
30 GRAPHIC ex4-8_006.jpg GRAPHIC 479588
31 GRAPHIC ex4-8_007.jpg GRAPHIC 461107
32 GRAPHIC ex4-8_008.jpg GRAPHIC 423010
33 GRAPHIC ex4-8_009.jpg GRAPHIC 338773
34 GRAPHIC ex4-8_010.jpg GRAPHIC 538156
35 GRAPHIC ex4-8_011.jpg GRAPHIC 492535
36 GRAPHIC ex4-8_012.jpg GRAPHIC 488994
37 GRAPHIC ex4-8_013.jpg GRAPHIC 464712
38 GRAPHIC ex4-8_014.jpg GRAPHIC 450146
39 GRAPHIC ex4-8_015.jpg GRAPHIC 99402
  Complete submission text file 0001213900-20-010632.txt   14883816

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE FILE enlv-20191231.xml EX-101.INS 935689
13 XBRL SCHEMA FILE enlv-20191231.xsd EX-101.SCH 78144
14 XBRL CALCULATION FILE enlv-20191231_cal.xml EX-101.CAL 67949
15 XBRL DEFINITION FILE enlv-20191231_def.xml EX-101.DEF 191569
16 XBRL LABEL FILE enlv-20191231_lab.xml EX-101.LAB 417771
17 XBRL PRESENTATION FILE enlv-20191231_pre.xml EX-101.PRE 328957
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Filer) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36578 | Film No.: 20835881
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences